Literature DB >> 8178989

Disposition of a mixed meal by the conscious dog.

M C Moore1, M J Pagliassotti, L L Swift, J Asher, J Murrell, D Neal, A D Cherrington.   

Abstract

The disposition of a mixed meal administered intragastrically was examined in 13 24-h-fasted conscious dogs, using the arteriovenous (AV) difference technique (and isotopic methods in 6 dogs). Postprandial net gut output totaled (in g of glucose equivalents) 42 +/- 6 glucose, 3 +/- 0.3 lactate, 2 +/- 0.2 alanine, and 0.2 +/- 0.0 glycerol. The gut oxidized 2 +/- 1 g of glucose, and 0.2 +/- 0.1 g remained within the intestinal lumen. Of the administered glucose 68 +/- 6% were accounted for, and volatile fatty acid production by the gut (n = 1) accounted for at least an additional 4%. Of the labeled glucose in the meal 82 +/- 5% appeared in the systemic circulation, an apparent overestimate of absorption of glucose from the meal. Cumulative net hepatic uptakes (in g of glucose equivalents) were 4.1 +/- 3.1 glucose, 12.1 +/- 2.1 gluconeogenic amino acids, and 1.5 +/- 0.2 glycerol. Net hepatic glycogen synthesis and lactate and CO2 production accounted for 6.2 +/- 4.1, 9.3 +/- 2.8, and 1.6 +/- 0.8 g of glucose equivalents, respectively. In summary, the AV difference method could account for the gut disposition of about two-thirds of the meal glucose. Nonsplanchnic tissues disposed of threefold more glucose than the liver. Net hepatic uptake of glucose equivalents as gluconeogenic amino acids was threefold > glucose uptake, and net hepatic uptake of gluconeogenic amino acids was > net gut release of gluconeogenic amino acids. In conclusion, the net hepatic uptake of glucose and gluconeogenic substrates provided adequate carbon for net hepatic synthesis of glycogen and production of lactate and CO2. In a net sense, peripheral tissues must have been the source of some of the gluconeogenic carbon taken up by the liver after the meal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178989     DOI: 10.1152/ajpendo.1994.266.4.E666

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Pregnancy augments hepatic glucose storage in response to a mixed meal.

Authors:  Mary Courtney Moore; Marta S Smith; Cynthia C Connolly
Journal:  Br J Nutr       Date:  2011-08-11       Impact factor: 3.718

Review 2.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

3.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

4.  The role of CCK8 in the inhibition of glucose production.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Alan D Cherrington
Journal:  Cellscience       Date:  2009-10-27

5.  Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs.

Authors:  Christopher J Ramnanan; Viswanathan Saraswathi; Marta S Smith; E Patrick Donahue; Ben Farmer; Tiffany D Farmer; Doss Neal; Philip E Williams; Margaret Lautz; Andrea Mari; Alan D Cherrington; Dale S Edgerton
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

6.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

7.  Hepatic glucose sensing is required to preserve β cell glucose competence.

Authors:  Pascal Seyer; David Vallois; Carole Poitry-Yamate; Frédéric Schütz; Salima Metref; David Tarussio; Pierre Maechler; Bart Staels; Bernard Lanz; Rolf Grueter; Julie Decaris; Scott Turner; Anabela da Costa; Frédéric Preitner; Kaori Minehira; Marc Foretz; Bernard Thorens
Journal:  J Clin Invest       Date:  2013-03-15       Impact factor: 14.808

8.  MetAP2 inhibitor treatment of high-fat and -fructose-fed dogs: impact on the response to oral glucose ingestion and a hyperinsulinemic hyperglycemic clamp.

Authors:  Mary Courtney Moore; Katie C Coate; Melanie Scott; Guillaume Kraft; James E Vath; Thomas E Hughes; Ben Farmer; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-01-28       Impact factor: 4.310

9.  Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day.

Authors:  Mary Courtney Moore; Marta S Smith; Ben Farmer; Katie C Coate; Guillaume Kraft; Masakazu Shiota; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2018-04-17       Impact factor: 9.461

10.  Portal infusion of amino acids is more efficient than peripheral infusion in stimulating liver protein synthesis at the same hepatic amino acid load in dogs.

Authors:  Dominique Dardevet; Scot R Kimball; Leonard S Jefferson; Alan D Cherrington; Didier Rémond; Catherine A DiCostanzo; Mary Courtney Moore
Journal:  Am J Clin Nutr       Date:  2008-10       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.